Emerging Technologies
Mount Sinai Health System, Nvidia and ARC Innovation Center leaders describe how their collaboration aims to decode the human genome using AI in order to more precisely predict disease risk and understand individual therapy response.
Science Corporation, a competitor of Elon Musk's Neuralink, offers a brain-computer interface retinal implant designed to restore vision in patients with macular degeneration.
The Massachusetts-based company will use the funds to advance its Spectris neurotechnology platform that uses visual and auditory stimulation to treat Alzheimer's disease.
It has demonstrated high accuracy in detecting pancreatic cancer by extracting and analysing 260,000 metabolic signals from just 500 microlitres of blood serum.
Funded by the Queensland government, a University of Queensland project is developing a VR program for practising safe falls for the first time among patients with spinal cord injury.
A neurologist's startup has developed a foundation model, based on 60,000 hours of brain wave records, which reportedly achieved 95% accuracy in identifying epilepsy biomarkers.
Shlomi Madar, CEO of SpotitEarly, discusses the company's noninvasive test using a breath sample, which is analyzed by specially trained dogs capable of identifying unique cancer-related scent signatures combined with AI technology.
The University of Kansas Health System, KU Medical Center, Children's Mercy and BAMF Health are partnering to develop a theranostics platform for adult and pediatric patients.
Extensive clinical validation and deployment are what remain to make it routine, according to University of New South Wales Scientia Professor Justin Gooding.
Emerging Technologies
Esther Kim, head of emerging technologies and solutions at Mass General Brigham, speaks with MobiHealthNews about evaluating new technologies through an operational lens and balancing innovation with real-world feasibility.